Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasia

Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasia

US Patent 6426349 · Granted Jul 30, 2002

Estimated economic value: $686,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of therapeutically treating cancer2025
Derivatives of sulindac can protect normal cells against oxidative damage2023
Indenyl compounds, pharmaceutical compositions, and medical uses thereof2022
Method of treating or preventing Ras-mediated diseases2021
Derivatives of sulindac can protect normal cells against oxidative damage2021
Indenyl compounds, pharmaceutical compositions, and medical uses thereof2021
Method of treating or preventing Ras-mediated diseases2021
Indenyl compounds, pharmaceutical compositions, and medical uses thereof2021
Indenyl compounds, pharmaceutical compositions, and medical uses thereof2021
Indenyl compounds, pharmaceutical compositions, and medical uses thereof2020
Ataxia telengiectasia and rad3-related (ATR) inhibitors and methods of their use2019
Treatment and diagnosis of cancer and precancerous conditions using PDE10A inhib2018